Clinical Trial: PBI for Low-risk Breast Cancer

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07814365) titled 'PBI for Low-risk Breast Cancer' on Sept. 04.

Brief Summary: This non-inferiority, phase 3 clinical trial evaluates the cosmetic non-inferiority of a one-week regimen (26 Gy/5 Fx) versus a three-week regimen (40 Gy/15 Fx) using intensity-modulated radiation therapy (IMRT) for partial breast irradiation (PBI) in low-risk breast cancer patients post-breast-conserving surgery. It also compares secondary outcomes including efficacy, safety, and quality of life between the two groups.

Study Start Date: Sept. 16, 2021

Study Type: INTERVENTIONAL

Condition: Early-Stage Breast Cancer

Intervention: RADIATION: 3-week PBI

40.05Gy/15Fx/3w...